Another fact that suggests the anti-tumoral potential of the proposed treatment was the upregulation of USHBP1 (FC = 1.50), also known as MCC2; this gene is not expressed in different kind of tumors and, together with its homologue MCC1, is considered a tumor suppressor [42]. Here, MCC is linked to neoplasm.